Headquartered in Montgomeryville, Pennsylvania, PhotoMedex (Nasdaq: PHMD) offers innovative solutions in the areas of dermatology, therapeutic skin care and surgical products. PhotoMedex develops proprietary excimer laser and fiber-optic systems for treatment of dermatological applications such as psoriasis and vitiligo. XTRAC® was the first FDA market-cleared excimer laser system for the treatment of dermatological applications such as psoriasis and vitiligo. The XTRAC system allows the physician to use the high dose of UVB energy of 308nm right to the spot of the problem for fast, effective treatment while minimizing the risk of exposure to healthy skin.
In March 2005, PhotoMedex acquired Procyte Corporation — a biotech company that develops and markets products based on its patented, clinically proven Copper Peptide technology for skin health, hair care and wound care. The combined company sells directly to dermatologists, plastic and cosmetic surgeons, spas and salons and through licenses with strategic partners into the consumer market, including its long-term worldwide license agreement with Neutrogena®, a Johnson & Johnson company. Procyte brands include Neova®, Ti-Silc®, VitalCopper®, Simple Solutions® and AquaSanté®.
A leader in the development, manufacturing and marketing of medical laser products, PhotoMedex offers unique and proprietary laser technology that provides significant benefits to the surgeon and to the patient. The Photomedex Contact Laser™ system offers unparalleled precision, versatility and hemostasis. PhotoMedex also offers innovative products for ENT Surgery and endoscopic imaging, such as the Bifrazier™ Bipolar Suction Coagulator and the ClearESS II irrigation and suction system for endoscopic sinus surgery.
To Achieve World-Class Medical Device Status by facilitating the cost-effective use of the highest quality medical technologies used to perform surgical procedures in doctors’ offices, hospitals and surgi-centers.